XML 114 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes
12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Income Taxes

12. Income Taxes

A reconciliation of the expected income tax benefit (expense) computed using the federal statutory income tax rate to the Company’s effective income tax rate was as follows:

 

     Year Ended December 31,  
     2014     2013     2012  

Income tax benefit computed at federal statutory tax rate

     34.00     34.00     34.00

State taxes, net of federal benefit

     5.05        4.67        5.19   

Change in valuation allowance

     (39.09     (39.43     (39.88

General business credits and other credits

     1.33        4.28        0.86   

Permanent differences

     (1.29     (3.52     (0.17
  

 

 

   

 

 

   

 

 

 

Total

  —     —     —  
  

 

 

   

 

 

   

 

 

 

The Company has incurred net operating losses, or NOLs, from inception. At December 31, 2014, the Company has federal and state NOL carryforwards of $84.9 million and $83.6 million, respectively, available to reduce future taxable income, that expire beginning in 2029 through 2034. The Company also had federal and state research and development tax credit carryforwards of $1.3 million and $977,000, respectively, available to reduce future tax liabilities that expire beginning in 2025 through 2034. Approximately $414,000 of the federal and state net operating loss carryforwards will result in an increase to additional paid-in capital if and when these carryforwards are used to reduce federal and state income taxes payable.

Under the provisions of the Internal Revenue Code, certain substantial changes in the Company’s ownership may result in a limitation on the amount of NOL carryforwards and research and development credit carryforwards that may be utilized annually to reduce future taxable income and taxes payable. The Company has not determined if a limitation has occurred.

 

The Company’s deferred tax assets consist of the following (in thousands):

 

     December 31,  
     2014      2013  

Deferred tax assets:

     

Net operating loss carryforwards

   $ 33,267       $ 21,085   

Research and development credit carryforwards

     1,979         1,511   

Accruals and other

     948         333   

Capitalized license and organization costs

     73         79   

Capitalized start-up costs

     309         340   
  

 

 

    

 

 

 

Total gross deferred tax asset

  36,576      23,348   

Deferred tax liability

  (18   (77

Valuation allowance

  (36,558   (23,271
  

 

 

    

 

 

 

Net deferred tax asset

$ —     $ —    
  

 

 

    

 

 

 

As required by ASC 740, Income Taxes (“ASC 740”), management of the Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets, which are composed principally of NOL carryforwards and research and development credit carryforwards. Management has determined that it is more likely than not that the Company will not recognize the benefits of its federal and state deferred tax assets, and, as a result, a valuation allowance of $36.6 million and $23.3 million has been established at December 31, 2014 and 2013, respectively. The change in the valuation allowance was $13.3 million for the year ended December 31, 2014. At December 31, 2014 and for prior periods, the Company had no unrecognized tax benefits. The Company has not, as yet, conducted a study of its research and development credit carryforwards. Such a study may result in an adjustment to the Company’s research and development credit carryforwards; however, until a study is completed and any adjustment is known, no amount is being presented as an uncertain tax position. A full valuation allowance has been provided against the Company’s research and development credits, and, if an adjustment is required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheets or statements of operations and comprehensive loss if an adjustment were required.

The Company applies the accounting guidance in ASC 740 related to accounting for uncertainty in income taxes. The Company’s reserves related to taxes are based on a determination of whether, and how much of, a tax benefit taken by the Company in its tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. As of December 31, 2014 and 2013, the Company had no unrecognized tax benefits. The Company recognizes interest and penalties related to uncertain tax positions in income tax expense.

The Company files income tax returns in the U.S. federal tax jurisdiction and the Massachusetts state jurisdiction. Since the Company is in a loss carryforward position, the Company is generally subject to examination by the U.S. federal, state and local income tax authorities for all tax years in which a loss carryforward is available. The Company does not have any international operations as of December 31, 2014. There are currently no federal or state audits in process.